<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Colorectal <z:mp ids='MP_0002038'>carcinomas</z:mp> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRCs</z:e>) with P53 mutations have been shown to be resistant to chemotherapy with <z:chebi fb="0" ids="46345">5-fluorouracil</z:chebi> (5-FU), the most widely used chemotherapeutic drug for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> treatment </plain></SENT>
<SENT sid="1" pm="."><plain>Autophagy is emerging as a promising therapeutic target for drug-resistant <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>In the present study, we tested the effects of <z:chebi fb="0" ids="9908">ursolic acid</z:chebi> (UA), a natural <z:chebi fb="0" ids="36615">triterpenoid</z:chebi>, on cell <z:hpo ids='HP_0011420'>death</z:hpo> mechanisms and its effects in combination with 5-FU in the HCT15 p53 mutant <z:mpath ids='MPATH_3'>apoptosis</z:mpath>-resistant <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cell line </plain></SENT>
<SENT sid="3" pm="."><plain>The involvement of UA in autophagy and its in vivo efficacy were evaluated </plain></SENT>
<SENT sid="4" pm="."><plain>Our data show that UA induces <z:mpath ids='MPATH_3'>apoptosis</z:mpath> independent of caspases in HCT15 cells and enhances 5-FU effects associated with an activation of c-jun N-terminal kinase (JNK) </plain></SENT>
<SENT sid="5" pm="."><plain>In this cell line, where this compound has a more pronounced effect on the induction of cell <z:hpo ids='HP_0011420'>death</z:hpo> compared to 5-FU, <z:mpath ids='MPATH_3'>apoptosis</z:mpath> corresponds only to a small percentage of the total cell <z:hpo ids='HP_0011420'>death</z:hpo> induced by UA </plain></SENT>
<SENT sid="6" pm="."><plain>UA also modulated autophagy by inducing the accumulation of LC3 and p62 levels with involvement of JNK pathway, which indicates a contribution of autophagy on JNK-dependent induction of cell <z:hpo ids='HP_0011420'>death</z:hpo> by UA </plain></SENT>
<SENT sid="7" pm="."><plain>By using <z:mp ids='MP_0003815'>nude</z:mp> mice xenografted with HCT15 cells, we verified that UA was also active in vivo decreasing <z:e sem="disease" ids="C0598934" disease_type="Neoplastic Process" abbrv="">tumor growth</z:e> rate </plain></SENT>
<SENT sid="8" pm="."><plain>In conclusion, this study shows UA's anticancer potential both in vitro and in vivo </plain></SENT>
<SENT sid="9" pm="."><plain>Induction of cell <z:hpo ids='HP_0011420'>death</z:hpo> and modulation of autophagy in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>-resistant cells were shown to involve JNK signaling </plain></SENT>
</text></document>